C/O DENNIS M. LANFEAR, REDWOOD CITY, CA
Coherus Oncology Enters $55 Million Senior Secured Term Loan Agreement
Contingent Value Rights Agreement
Reports Second Quarter 2026 Financial Results and Provides Business Update
2026 Annual Meeting of Stockholders Voting Results - Coherus Oncology, Inc.
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Financial Results, Press Release
Coherus Oncology Enters Underwriting Agreement for 28.6 Million Shares
Q2
FY 2025
Q3
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
SC TO-I
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
PREM14A
Submission Upload
Correspondence